These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35917806)

  • 21. The Effect of Buprenorphine on Methamphetamine Cravings.
    Salehi M; Emadossadat A; Kheirabadi GR; Maracy MR; Sharbafchi MR
    J Clin Psychopharmacol; 2015 Dec; 35(6):724-7. PubMed ID: 26468683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oxytocin on methamphetamine-seeking exacerbated by predator odor pre-exposure in rats.
    Ferland CL; Reichel CM; McGinty JF
    Psychopharmacology (Berl); 2016 Mar; 233(6):1015-24. PubMed ID: 26700240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K
    Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bupropion for the treatment of methamphetamine dependence.
    Elkashef AM; Rawson RA; Anderson AL; Li SH; Holmes T; Smith EV; Chiang N; Kahn R; Vocci F; Ling W; Pearce VJ; McCann M; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Weis D
    Neuropsychopharmacology; 2008 Apr; 33(5):1162-70. PubMed ID: 17581531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OXYTOCIN - AN EMERGING TREATMENT FOR OBESITY AND DYSGLYCEMIA: REVIEW OF RANDOMIZED CONTROLLED TRIALS AND COHORT STUDIES.
    Barengolts E
    Endocr Pract; 2016 Jul; 22(7):885-94. PubMed ID: 27018619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short circuit: Disaggregation of adrenocorticotropic hormone and cortisol levels in HIV-positive, methamphetamine-using men who have sex with men.
    Carrico AW; Rodriguez VJ; Jones DL; Kumar M
    Hum Psychopharmacol; 2018 Jan; 33(1):. PubMed ID: 29266420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study.
    Woolley JD; Arcuni PA; Stauffer CS; Fulford D; Carson DS; Batki S; Vinogradov S
    Psychopharmacology (Berl); 2016 Jul; 233(13):2571-80. PubMed ID: 27137199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
    Miles SW; Sheridan J; Russell B; Kydd R; Wheeler A; Walters C; Gamble G; Hardley P; Jensen M; Kuoppasalmi K; Tuomola P; Föhr J; Kuikanmäki O; Vorma H; Salokangas R; Mikkonen A; Kallio M; Kauhanen J; Kiviniemi V; Tiihonen J
    Addiction; 2013 Jul; 108(7):1279-86. PubMed ID: 23297867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unaltered Oxytocin and Vasopressin Plasma Levels in Patients with Schizophrenia After 4 Months of Daily Treatment with Intranasal Oxytocin.
    Busnelli M; Dagani J; de Girolamo G; Balestrieri M; Pini S; Saviotti FM; Scocco P; Sisti D; Rocchi M; Chini B
    J Neuroendocrinol; 2016 Apr; 28(4):. PubMed ID: 26715485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ON-ICE trial: Investigation of the combined effects of oxytocin and naltrexone on stress-induced and alcohol cue-induced craving in alcohol use disorder-Study protocol of a phase II randomised double-blind placebo-controlled parallel-group trial.
    Zimmermann S; Thomas BC; Krisam J; Limprecht R; Klose C; Stenger M; Pourbaix M; Ries M; Vollstaedt-Klein S; Koopmann A; Lenz B; Kiefer F; Bach P
    BMJ Open; 2022 Apr; 12(4):e059672. PubMed ID: 35410938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of patients with methamphetamine dependence with cue-elicited heart rate variability in a virtual social environment.
    Wang YG; Shen ZH; Wu XC
    Psychiatry Res; 2018 Dec; 270():382-388. PubMed ID: 30300868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence.
    Ezard N; Dunlop A; Hall M; Ali R; McKetin R; Bruno R; Phung N; Carr A; White J; Clifford B; Liu Z; Shanahan M; Dolan K; Baker AL; Lintzeris N
    BMJ Open; 2018 Jul; 8(7):e020723. PubMed ID: 30030312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
    Johnson BA; Ait-Daoud N; Elkashef AM; Smith EV; Kahn R; Vocci F; Li SH; Bloch DA;
    Int J Neuropsychopharmacol; 2008 Feb; 11(1):1-14. PubMed ID: 17470315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative moods correlate with craving in female methamphetamine users enrolled in compulsory detoxification.
    Shen W; Liu Y; Li L; Zhang Y; Zhou W
    Subst Abuse Treat Prev Policy; 2012 Oct; 7():44. PubMed ID: 23110820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal Oxytocin Selectively Modulates Social Perception, Craving, and Approach Behavior in Subjects With Alcohol Use Disorder.
    Mitchell JM; Arcuni PA; Weinstein D; Woolley JD
    J Addict Med; 2016; 10(3):182-9. PubMed ID: 27159342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial.
    Morabbi MJ; Razaghi E; Moazen-Zadeh E; Safi-Aghdam H; Zarrindast MR; Vousoghi N; Akhondzadeh S
    Int Clin Psychopharmacol; 2018 Mar; 33(2):111-119. PubMed ID: 29064909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine hydrochloride attenuates voluntary methamphetamine consumption and anxiety-like behaviors via modulation of oxytocin receptors in methamphetamine addicted rats.
    Alavijeh MM; Vaezi G; Khaksari M; Hojati V
    Physiol Behav; 2019 Jul; 206():157-165. PubMed ID: 30922821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal oxytocin alters amygdala-temporal resting-state functional connectivity in body dysmorphic disorder: A double-blind placebo-controlled randomized trial.
    Grace SA; Labuschagne I; Castle DJ; Rossell SL
    Psychoneuroendocrinology; 2019 Sep; 107():179-186. PubMed ID: 31146138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of effects of ifenprodil in patients with methamphetamine dependence: Protocol for an exploratory, randomized, double-blind, placebo-controlled trial.
    Kotajima-Murakami H; Takano A; Ogai Y; Tsukamoto S; Murakami M; Funada D; Tanibuchi Y; Tachimori H; Maruo K; Sasaki T; Matsumoto T; Ikeda K
    Neuropsychopharmacol Rep; 2019 Jun; 39(2):90-99. PubMed ID: 30756527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.